Mitral Valve Repair in India & UAE

Mitral valve repair in India from $6,000. Repair of mitral regurgitation and prolapse at Apollo, Medanta, Fortis. 96% success, 15+ year durability. Book a free consultation today.

Estimated cost: $6,000 – $10,000 · Average stay: 7–10 days

Mitral valve repair is the gold standard treatment for significant mitral valve regurgitation (MR) — the backward leakage of blood through a defective mitral valve from the left ventricle back into the left atrium with each heartbeat. Unlike valve replacement (which substitutes the diseased valve with a mechanical or biological prosthesis), repair reconstructs and preserves the patient's own native valve, achieving superior long-term cardiac function, avoiding the need for lifelong anticoagulation in most cases, and providing remarkably durable results.

The mitral valve is the most complex of the four heart valves. It has two leaflets (anterior and posterior) connected by hundreds of thin fibrous chordae tendineae to two papillary muscles in the left ventricular wall. The leaflet edges must coapt (meet precisely) along the entire coaptation line with each heartbeat to prevent regurgitation. Any disruption — prolapse of a leaflet (the most common cause in Western countries), rupture of chordae tendineae, rheumatic scarring (the most common cause in developing countries including India), annular dilation (dilatation of the fibrous ring supporting the valve), or infective endocarditis — impairs coaptation and causes regurgitation.

India has both the highest burden of rheumatic mitral valve disease in the world — rheumatic fever from inadequately treated streptococcal throat infections causes mitral stenosis and mixed mitral valve disease affecting millions of Indians, particularly in rural areas — and a growing degenerative MR burden as the population ages. India's cardiac surgery centers offer expert mitral valve repair for both rheumatic and degenerative disease at a fraction of Western costs. Apollo Hospitals Chennai, Medanta – The Medicity, Jaslok Hospital Mumbai, Fortis Memorial Research Institute, and Kokilaben Dhirubhai Ambani Hospital have surgeons with specific mitral valve repair expertise who have trained at world-leading valve surgery programs.

The cost of mitral valve repair in India is $6,000–$10,000 — compared to $30,000–$60,000 in the United States and $18,000–$30,000 in the UK. For patients with significant mitral regurgitation who want the best chance of repair (preserving their native valve) rather than replacement, India's combination of expert repair surgeons and affordable pricing represents an extraordinary opportunity.

What is Mitral Valve Repair and When is it Better Than Replacement?

The European Society of Cardiology and American College of Cardiology guidelines both state clearly: mitral valve repair is preferred over replacement whenever technically feasible and durable repair is predicted. The evidence for this preference is overwhelming:

1. Better preservation of left ventricular function: the native subvalvular apparatus (chordae and papillary muscles) contributes importantly to left ventricular geometry and systolic function. Repair preserves this; replacement with chordal-severing technique impairs LV function permanently.

1. No need for anticoagulation: repaired valves do not require lifelong anticoagulation (unlike mechanical replacements). Aspirin alone suffices for most patients with degenerative MR after repair.

1. Lower operative mortality: isolated mitral repair carries a 30-day mortality under 0.5% at expert centers; replacement carries 1–2% even in optimal cases.

1. Excellent long-term durability: 80–95% of degenerative mitral repairs are free from reoperation at 15–20 years at specialized centers. Rheumatic mitral repairs have lower durability (60–70% at 10 years) due to the continuing rheumatic process.

1. Freedom from prosthetic valve complications: no risk of prosthetic valve thrombosis, structural deterioration, or endocarditis on a prosthetic material.

The techniques of mitral repair vary with the pathology: resection of the prolapsing segment and reapproximation (quadrangular or triangular resection); artificial chordae replacement with expanded PTFE sutures; chordal transfer from the anterior to the posterior leaflet; edge-to-edge (Alfieri) suture approximation; leaflet augmentation with autologous pericardium (for rheumatic commissurotomy and leaflet augmentation); and annuloplasty ring implantation (always performed to stabilize and reshape the annulus — the critical step that ensures repair durability).

Who Needs Mitral Valve Repair?

Symptomatic severe mitral regurgitation: surgery indicated when the patient has symptoms attributable to MR (breathlessness, reduced exercise tolerance, palpitations) and the valve is repair-amenable. Asymptomatic severe MR: guidelines now support early surgery when: LV function is declining (LVEF dropping below 60% or LVESD above 40 mm); atrial fibrillation has developed; pulmonary hypertension is present; or — at centers with documented very high repair rates (above 95%) — as prophylactic early repair to prevent these complications.

Repair is more likely to succeed (and more durable long-term) for: isolated posterior leaflet prolapse (the easiest to repair); degenerative (Barlow's or fibroelastic deficiency) MR; and non-rheumatic disease. Rheumatic MR (from rheumatic heart disease — leaflet restriction and thickening from inflammation) can be repaired at specialist centers but durability is lower (60–70% at 10 years) because the rheumatic process continues. Mitral stenosis from rheumatic disease is often better treated by percutaneous balloon mitral valvuloplasty (if valve anatomy is favorable) or mitral valve replacement with a longer-duration prosthesis.

How is Mitral Valve Repair Performed?

Mitral valve repair is performed via sternotomy (standard) or right mini-thoracotomy (minimally invasive) under cardiopulmonary bypass. The heart is arrested; the left atrium is opened behind the interatrial groove to expose the mitral valve.

The surgeon systematically examines every component of the valve — both leaflets at each scallop, all chordal structures, the papillary muscles, and the annulus — under bright illumination and loupe magnification (usually 2.5–3.5×). The pathological anatomy is precisely mapped. The repair strategy is formulated before any incision is made to the valve tissue.

For prolapse from chordal rupture: artificial PTFE chordae are attached from the papillary muscle tip to the free edge of the prolapsing leaflet at the correct length, re-establishing normal leaflet geometry. For leaflet prolapse without chordal rupture: leaflet resection (removing the prolapsing segment) with re-approximation of the remaining leaflet edges. For annular dilation: an appropriately sized annuloplasty ring (rigid or flexible; complete or partial) is selected and sutured circumferentially around the posterior half or complete circumference of the annulus.

The repair is tested with a saline pressure test (a large syringe of saline injected retrograde through the aortic root into the LV to fill the left ventricle under pressure — the valve should coapt completely, holding all the saline without any regurgitation visible). The left atrium is then closed, the heart restarted, and intraoperative transesophageal echocardiography (TEE) performed on the beating heart under physiological load — the definitive quality check. Any residual regurgitation above "trace" prompts return to bypass for revision or conversion to replacement.

Procedure Steps

1. Pre-operative: 3D TEE for precise leaflet-by-leaflet anatomy mapping; coronary angiography (patients over 40); cardiac CT if considering minimally invasive approach.
2. Anesthesia: general anesthesia; TEE probe; arterial line; central venous catheter.
3. Incision: standard sternotomy or 4–5 cm right anterolateral mini-thoracotomy.
4. Cardiopulmonary bypass and cardiac arrest.
5. Left atriotomy: left atrium opened via the interatrial groove or transseptal (right-sided mini thoracotomy approach).
6. Valve analysis: systematic inspection of posterior leaflet scallops (P1, P2, P3), anterior leaflet (A1, A2, A3), chordae, papillary muscles, annulus.
7. Repair technique: artificial chordae (Gore-Tex) for chordal rupture; leaflet resection for localized prolapse; pericardial augmentation for leaflet restriction in rheumatic disease.
8. Annuloplasty: ring selection and sizing; interrupted 2-0 sutures placed in the annulus; ring seated and tied.
9. Saline pressure test: confirms complete leaflet coaptation and no regurgitation.
10. Left atrium closed; heart restarted; intraoperative TEE confirms result.
11. Weaning from bypass; sternal closure or mini-thoracotomy closure; ICU transfer.

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $30,000 – $60,000 — Baseline

United Kingdom — $18,000 – $35,000 — ~42% savings vs. USA

Germany — $15,000 – $28,000 — ~52% savings vs. USA

India — $6,000 – $10,000 — Up to 83% savings vs. USA

UAE — $12,000 – $25,000 — ~60% savings vs. USA

Mitral valve repair packages in India include surgery, cardiopulmonary bypass team, ICU (1–2 days), ward stay (5–7 days), annuloplasty ring and PTFE sutures (if needed), intraoperative TEE, and post-operative care. Gaf Healthcare verifies the specific repair rates of recommended surgeons — the single most important quality metric for mitral surgery. We target surgeons with documented repair rates above 95% for degenerative MR.

Recovery & Follow-up

Recovery follows standard open-heart surgery timelines: ICU 1–2 days; ward 5–7 days; total hospital stay 7–10 days; sternal healing 6–8 weeks. Return to desk work at 6–8 weeks; full physical activity at 10–12 weeks.

Most repair patients do not need anticoagulation — a major quality-of-life advantage. Aspirin 75–100 mg is prescribed. Echocardiography at 6 weeks post-operatively documents the repair result and provides a new baseline. Annual echocardiogram thereafter monitors for repair durability.

Atrial fibrillation — present in 30–50% of patients with chronic severe MR — typically does not resolve immediately after repair. Cardioversion and/or antiarrhythmic therapy is needed; surgical MAZE ablation (combined with valve repair) is offered at centers with AF ablation expertise.

Recovery Tips

• Attend the 6-week echocardiogram — confirms the repair is durable and provides your post-repair baseline.
• Take aspirin 75–100 mg daily; if AF persists, continue anticoagulation as directed.
• Cardiac rehabilitation from 6–8 weeks — significantly improves exercise capacity and reduces AF recurrence.
• Annual echocardiogram for life — mitral repair durability is monitored by the residual regurgitation grade.
• Notify dentist and surgeons of your mitral repair history — antibiotic prophylaxis before dental procedures is recommended.
• Report new breathlessness, palpitations, or increased leg swelling — may indicate repair failure or new AF.

Risks & Complications

At experienced centers, isolated mitral repair mortality is under 0.3–0.5%. Specific risks: repair failure at the time of surgery requiring conversion to replacement (1–3% at expert centers); post-operative AF (40–50% — usually transient; managed with cardioversion); bleeding requiring re-exploration (2–3%); stroke (less than 1%); and late repair failure requiring reoperation (5–10% at 10 years for posterior leaflet repair; higher for complex anterior leaflet or bileaflet repairs; higher for rheumatic disease). Permanent pacemaker is rarely required after isolated mitral repair. The skill of the specific surgeon determines repair success rates more than any other factor.

Why GAF Healthcare

Gaf Healthcare identifies mitral valve repair surgeons in India whose personal posterior leaflet repair rates exceed 98% and whose overall degenerative MR repair rates exceed 95% — the benchmarks of specialized valve surgery programs. We arrange pre-operative 3D TEE imaging for precise leaflet mapping before the surgical consultation, facilitate telemedicine review by the surgeon, and coordinate post-operative echocardiographic follow-up before international patients fly home.

Frequently Asked Questions

What is the success rate of mitral valve repair in India?

At India's specialized mitral valve repair centers, repair rates exceed 95–98% for isolated posterior leaflet prolapse (the most common pathology) and 85–90% for complex anterior or bileaflet repairs. Long-term durability is 85–90% at 15 years for degenerative MR repairs. These outcomes match the world's leading valve surgery programs.

What is the difference between mitral valve repair and mitral valve replacement?

Repair reconstructs and preserves the native valve — better long-term heart function, no anticoagulation needed, lower mortality, and superior durability in degenerative disease. Replacement substitutes the diseased valve with a mechanical (lasts forever, requires warfarin) or tissue (lasts 10–15 years, no anticoagulation) prosthesis. Replacement is required when the valve cannot be reliably repaired.

How long does a repaired mitral valve last?

80–90% of degenerative mitral valve repairs are durable at 15–20 years. Rheumatic repairs have lower durability (60–70% at 10 years) because the inflammatory rheumatic process continues. Annual echocardiography monitors the repair and detects early failure before heart function is compromised.

What is the cost of mitral valve repair in India?

Mitral valve repair costs $6,000–$10,000 in India — compared to $30,000–$60,000 in the USA. The package includes surgery, annuloplasty ring, intraoperative TEE, ICU and hospital stay.